RhumbLine Advisers’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-862	Closed	-$16K	–	3307
2022 Q1	$16K	Buy	862 +21	+2%	+$390	﹤0.01%	3005
2021 Q4	$30K	Buy	+841	New	+$30K	﹤0.01%	2997